Remed Co (XKRX:302550) Stock Based Compensation : ₩120 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Remed Co Stock Based Compensation?

Remed Co's Stock Based Compensation for the three months ended in Dec. 2023 was ₩29 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was ₩120 Mil.

Remed Co Stock Based Compensation Historical Data

The historical data trend for Remed Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remed Co Stock Based Compensation Chart

Remed Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Stock Based Compensation

Get a 7-Day Free Trial

665.36

558.44

83.18

59.45

120.22

Remed Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Stock Based Compensation	Get a 7-Day Free Trial															15.85	34.48	28.37	28.68	28.68

Remed Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩120 Mil.

Remed Co Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Remed Co's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Remed Co (XKRX:302550) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Remed Co Ltd (XKRX:302550) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

N/A

Address

187 Techno 2-ro, No 301-303, Gwanpyeong-dong, Yuseong-gu, Daejeon, KOR, 34025

Website

http://www.remed.kr

Remed Co Ltd is a Korean medical equipment manufacturing company. The company is engaged in researching and developing products to treat brain disorders such as depression, anxiety, stroke and Parkin's. It has developed TMS device and is manufacturing pain therapy devices using advanced electromagnetic stimulation, shockwave (RSWT) and laser technologies. Its products offerings include Transcranial Magnetic simulator for brain, Electromagnetic simulators including Salus Talent, Salus Talent A, Salus Talent Pro, and Optimus Pro for pain therapy; and Rosetta, Salus RSWT and Optimus Pro as a part of Extracorporeal Shockwave Therapy. It also offers Electrosurgical units from REMED including ELPIS 4L, ELPIS 4, ELPIS 3, and ELPIS2.

Remed Co (XKRX:302550) Headlines

No Headlines